Brown, Lisle/Cummings’s Bruker BRKR Stock Holding History

Brown, Lisle/Cummings’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.63K	Sell	27 -17	-39%	-$793	﹤0.01%	894
2026 Q1	$1.59K	Buy	+44	New	+$1.84K	﹤0.01%	863

Other funds holding BRKR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

Brown, Lisle/Cummings's BRKR Position: Q2 2026 in Review

Brown, Lisle/Cummings reduced its Bruker (BRKR) stake by 39% in Q2 2026, selling an estimated $793 and leaving 27 shares worth $1.63K. The position accounts for ﹤0.01% of the portfolio, ranked #894.

Brown, Lisle/Cummings first reported a position in BRKR in Q1 2026 and has held it in 2 quarters since. 417 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

Brown, Lisle/Cummings held 27 shares of Bruker worth $1.63K as of Q2 2026.
Brown, Lisle/Cummings sold 17 Bruker shares in Q2 2026, an estimated $793.
Bruker made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #894 holding.
Brown, Lisle/Cummings first reported a position in Bruker in Q1 2026 and has held it in 2 quarters since.
417 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.